Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Association between Brain Amyloid Status and Cognitive and Physical Performance in Older Adults with Frailty Criteria: Longitudinal Data from the CogFrail Study.

Created on 15 Nov 2026

Authors

Davide Angioni, Federico Bellelli, Christelle Cantet, Gaelle Soriano, Pierre Payoux, Bruno Vellas, Julien Delrieu, Sandrine Andrieu, Sandrine Sourdet

Published in

The journals of gerontology. Series A, Biological sciences and medical sciences. Nov 14, 2026. Epub Nov 14, 2026.

Abstract

The impact of cerebral amyloid pathology on cognitive and functional decline may differ with age. Evidence linking brain amyloidopathy to physical decline remains limited and inconsistent. This study investigated the association between brain amyloid status and cognitive and physical decline in (pre)frail older adults with cognitive impairment.
This longitudinal analysis used data from the CogFrail study. Brain amyloid pathology was assessed using amyloid-positron emission tomography (visual reading). Linear mixed-effects models examined differences over a two-year follow-up between amyloid-positive and amyloid-negative participants in cognitive, functional, and physical trajectories. Cognitive and functional outcomes included the Mini-Mental State Examination, the Clinical Dementia Rating-Sum of Boxes, the Activities of Daily Living Index, and a neuropsychological battery, while the physical domain was assessed using handgrip strength, chair rise time, gait speed, and the Short Physical Performance Battery.
Among 199 participants (mean age 82.3 ± 4.8 years; 65.3% women), 108(54.3%) were amyloid-positive. Amyloid-positive participants experienced greater decline in the Clinical Dementia Rating-Sum of Boxes (β = 0.30, 95% CI 0.10-0.49; p = 0.003, log-transformed) and the Mini-Mental State Examination (β = -1.62, 95% CI -2.74 to -0.49; p = 0.005). No significant longitudinal differences were observed between groups in the Activities of Daily Living Index, neuropsychological outcomes, or physical performance measures.
Amyloid pathology assessment may help differentiate cognitive trajectories in cognitively impaired (pre)frail older adults. Greater cognitive decline in amyloid-positive participants was not associated with greater loss of independence or additional physical decline over time.
NCT03129269.

PMID:
43033223
Bibliographic data and abstract were imported from PubMed on 15 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 8
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement